{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:44:20Z","timestamp":1785861860720,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.wnf.0000240945.44370.f0","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T04:00:59Z","timestamp":1170043259000},"page":"43-46","source":"Crossref","is-referenced-by-count":44,"title":["Two Years' Follow-up of Rivastigmine Treatment in Huntington Disease"],"prefix":"10.1097","volume":"30","author":[{"given":"Marina","family":"de Tommaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Difruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sciruicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Specchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Livrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"12","key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/mds.20235","article-title":"Efficacy of rivastigmine on motor and cognitive impairment in Huntington's disease.","volume":"19","author":"de Tommaso","year":"2004","journal-title":"Mov Disord"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","article-title":"Huntington's disease: functional capacities in patients treated with neuroleptic and antidepressant drugs.","volume":"31","author":"Shoulson","year":"1981","journal-title":"Neurology"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0278-5846(00)00153-6","article-title":"Role of tonically-active neurons in the control of striatal function: cellular mechanism and behavioral correlates.","volume":"25","author":"Pisani","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised, controlled trial.","volume":"318","author":"Rosler","year":"1999","journal-title":"BMJ"},{"key":"R5-7-20210203","first-page":"CD004747","article-title":"Cholinesterase inhibitors for Parkinson's disease dementia.","volume":"1","author":"Maidment","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/87565649109540545","article-title":"The Mini Mental State Examination: normative study of an Italian random sample.","volume":"9","author":"Measso","year":"1993","journal-title":"Dev Neuropsychol"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2125.1981.tb01118.x","article-title":"Assessment of extrapyramidal disorders.","volume":"11","author":"Marsden","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency.","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.46.2.527","article-title":"Trinucleotide repeat length and clinical progression in Huntington's disease.","volume":"46","author":"Brandt","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004850-200403000-00001","article-title":"Huntington's disease: present treatments and future therapeutic modalities.","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.wnf.0000240945.44370.f0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:44:11Z","timestamp":1785858251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200701000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.wnf.0000240945.44370.f0","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}